For: | Ghouri A, Quicke JG, Conaghan PG. New developments in osteoarthritis pharmacological therapies. Rheumatology (Oxford) 2021;60:vi1-vi11. [PMID: 34951922 DOI: 10.1093/rheumatology/keab679] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis] |
---|
Number | Citing Articles |
1 | Tenti S, Bruyère O, Cheleschi S, Reginster JY, Veronese N, Fioravanti A. An update on the use of conventional and biological disease-modifying anti-rheumatic drugs in hand osteoarthritis. Ther Adv Musculoskelet Dis 2023;15:1759720X231158618. [PMID: 36937821 DOI: 10.1177/1759720X231158618] [Reference Citation Analysis] |
2 | Sewell J, Östör A. Emerging injectable therapies for osteoarthritis. Expert Opin Emerg Drugs 2022;27:311-20. [PMID: 36102303 DOI: 10.1080/14728214.2022.2125506] [Reference Citation Analysis] |
3 | 朱 玉. The Role of Infrapatellar Fat Pad in Knee Osteoarthritis. ACM 2022;12:5160-5165. [DOI: 10.12677/acm.2022.126748] [Reference Citation Analysis] |